HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues.

Abstract
Ambroxol is a widely used secretolytic agent originally developed from vasicine, a natural alkaloid found in Adhatoda vasica, extracts of which have been used to treat bronchitis, asthma, and rheumatism. We previously reported that ambroxol inhibits IgE-dependent mediator secretion from human mast cells and basophils, key effector cells of allergic inflammation. Here, the mechanisms involved in the inhibitory properties of ambroxol were assessed in comparison to other secretolytic analogues (e.g. vasicine, bromhexine, sputolysin). The results show that, in comparison to ambroxol, which reduced IgE-dependent histamine release from basophils at 10 microM-1 mM, the release of the amine was only moderately reduced by sputolysin and vasicine at 1 mM. In contrast, above 10 microM, bromhexine was found to be toxic to basophils in vitro as evidenced by induction of histamine release and reduced cell viability. In contrast, the inhibitory actions of ambroxol at concentrations below 1 mM were not toxic and entirely reversible. Ambroxol was also more potent than either sputolysin or vasicine in attenuating basophil IL-4 and IL-13 secretions, whereas bromhexine-induced suppression of de novo cytokine synthesis was due to toxic effects. Additionally, ambroxol reduced IgE-dependent p38 MAPK phosphorylation in basophils, unlike bromhexine, sputolysin and vasicine. These results clearly show that ambroxol is both more potent and effective at inhibiting IgE-dependent basophil mediator release and p38 MAPK activity than the other secretolytic analogues employed. The therapeutic potential of ambroxol as an anti-allergic agent is further underlined by these data.
AuthorsB F Gibbs
JournalInternational journal of immunopathology and pharmacology (Int J Immunopathol Pharmacol) 2009 Oct-Dec Vol. 22 Issue 4 Pg. 919-27 ISSN: 0394-6320 [Print] England
PMID20074455 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Alkaloids
  • Anti-Allergic Agents
  • Expectorants
  • IL4 protein, human
  • Interleukin-13
  • Quinazolines
  • Ambroxol
  • Interleukin-4
  • Immunoglobulin E
  • vasicine
  • p38 Mitogen-Activated Protein Kinases
  • Bromhexine
  • Dithiothreitol
Topics
  • Alkaloids (pharmacology)
  • Ambroxol (pharmacology, toxicity)
  • Anti-Allergic Agents (pharmacology, toxicity)
  • Basophils (drug effects, immunology)
  • Bromhexine (pharmacology)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Dithiothreitol (pharmacology)
  • Dose-Response Relationship, Drug
  • Expectorants (pharmacology, toxicity)
  • Histamine Release (drug effects)
  • Humans
  • Immunoglobulin E (immunology)
  • Interleukin-13 (metabolism)
  • Interleukin-4 (metabolism)
  • Phosphorylation
  • Quinazolines (pharmacology)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: